| Nitazoxanide superiority to placebo to treat moderate COVID-19–A Pilot prove of concept randomized double-blind clinical trial. VF Blum, S Cimerman, JR Hunter, P Tierno, A Lacerda, A Soeiro, ... EClinicalMedicine 37, 2021 | 60 | 2021 |
| Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial RS Diaz, IL Shytaj, LB Giron, B Obermaier, E della Libera Jr, J Galinskas, ... International journal of antimicrobial agents 54 (5), 592-600, 2019 | 39 | 2019 |
| The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use ECS Ricardo Sobhie Diaz, Lilian A. Inocêncio, Maria Cecilia Araripe Sucupira ... PLoS ONE 10 (10), 2015 | 30 | 2015 |
| Detection of coinfection with Chikungunya virus and Dengue virus serotype 2 in serum samples of patients in State of Tocantins, Brazil SM Robson dos Santos, RLS Duro, GL Santos, J Hunter, MAR Teles, ... Journal of infection and public health 13 (5), 724-729, 2020 | 24 | 2020 |
| Late presentation HIV/AIDS is still a challenge in Brazil and worldwide SV Komninakis, ML Mota, JR Hunter, RS Diaz AIDS research and human retroviruses 34 (2), 129-131, 2018 | 20 | 2018 |
| Pace of coreceptor tropism switch in HIV-1-infected individuals after recent infection MS Arif, J Hunter, AR Leda, JPL Zukurov, S Samer, M Camargo, ... Journal of virology 91 (19), 10.1128/jvi. 00793-17, 2017 | 20 | 2017 |
| Nicotinamide activates latent HIV-1 ex vivo in ART suppressed individuals, revealing higher potency than the association of two methyltransferase inhibitors, chaetocin and BIX01294 S Samer, MS Arif, LB Giron, JPL Zukurov, J Hunter, BT Santillo, ... Brazilian Journal of Infectious Diseases 24, 150-159, 2020 | 16 | 2020 |
| Environmental changes and the impact on the human infections by dengue, chikungunya and Zika viruses in northern Brazil, 2010–2019 RSS Marinho, RLS Duro, MTO Mota, J Hunter, RS Diaz, FS Kawakubo, ... International Journal of Environmental Research and Public Health 19 (19), 12665, 2022 | 15 | 2022 |
| HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country MFR Nutini, J Hunter, L Giron, AFNPC Pires, IM Kohiyama, M Camargo, ... PLoS One 15 (1), e0227082, 2020 | 15 | 2020 |
| Nitazoxanide superiority to placebo to treat moderate COVID-19–a pilot prove of concept randomized double-blind clinical trial. eClinicalMedicine. 2021; 37: 100981 VF Blum, S Cimerman, JR Hunter, P Tierno, A Lacerda, A Soeiro, ... DOI: https://doi. org/10.1016/j. eclinm, 100981, 2021 | 13 | 2021 |
| Re-emergence of mayaro virus and coinfection with chikungunya during an outbreak in the state of Tocantins/Brazil R dos Santos Souza Marinho, RLS Duro, D Bellini Caldeira, J Galinskas, ... BMC Research Notes 15 (1), 271, 2022 | 10 | 2022 |
| Serological and molecular epidemiology of the Dengue, Zika and Chikungunya viruses in a risk area in Brazil ML Mota, R dos Santos Souza Marinho, RLS Duro, J Hunter, ... BMC Infectious Diseases 21, 1-7, 2021 | 10 | 2021 |
| Effective phage cocktail to combat the rising incidence of extensively drug-resistant Klebsiella pneumoniae sequence type 16 WMBS Martins, M Li, K Sands, MH Lenzi, E Portal, J Mathias, PP Dantas, ... Emerging Microbes & Infections 11 (1), 1015-1023, 2022 | 9 | 2022 |
| HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals AR Leda, J Hunter, UC de Oliveira, IJ de Azevedo, EG Kallas, ... Virology 541, 13-24, 2020 | 8 | 2020 |
| Insights about minority HIV-1 strains in transmitted drug resistance mutation dynamics and disease progression AR Leda, J Hunter, UC Oliveira, IJ Azevedo, MCA Sucupira, RS Diaz Journal of Antimicrobial Chemotherapy 73 (7), 1930-1934, 2018 | 8 | 2018 |
| Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil RS Diaz, JR Hunter, M Camargo, D Dias, J Galinskas, I Nassar, ... BMC Infectious Diseases 23 (1), 347, 2023 | 7 | 2023 |
| Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II … MV de Almeida Baptista, LT da Silva, S Samer, TM Oshiro, IL Shytaj, ... AIDS research and therapy 19 (1), 2, 2022 | 5 | 2022 |
| The clinical course of hospitalized moderately ill COVID-19 patients is mirrored by routine hematologic tests and influenced by renal transplantation PM Peçanha-Pietrobom, GGF Leite, J Hunter, PRA Ferreira, MN Burattini, ... PLoS One 16 (11), e0258987, 2021 | 5 | 2021 |
| Nitazoxanide In Vitro Efficacy Against SARS CoV-2 and In Vivo Superiority to Placebo to Treat Moderate COVID-19 – A Phase 2 Randomized Double-Blind … VF Blum, S Cimerman, JR Hunter, P Tierno, A Lacerda, A Soeiro, ... | 4 | 2021 |
| Identification of a new hepatitis B virus recombinant D2/D3 in the city of São Paulo, Brazil LC Santana, NP Mantovani, MC Ferreira, R Arnold, RLS Duro, ... Archives of virology 162, 457-467, 2017 | 4 | 2017 |
Ricardo Sobhie DiazAssociate Professor, Infectious Diseases Division, Paulista School of Medicine, Federal UniversityVerified email at catg.com.br
